Luo W - Search Results

1

Design, synthesis, physicochemical properties, and evaluation of novel iron chelators with fluorescent sensors.

Ma Y, Luo W, Quinn PJ, Liu Z, Hider RC. Ma Y, et al. Among authors: luo w. J Med Chem. 2004 Dec 2;47(25):6349-62. doi: 10.1021/jm049751s. J Med Chem. 2004. PMID: 15566304

2

Design, synthesis and properties of novel iron(III)-specific fluorescent probes.

Luo W, Ma YM, Quinn PJ, Hider RC, Liu ZD. Luo W, et al. J Pharm Pharmacol. 2004 Apr;56(4):529-36. doi: 10.1211/0022357023196. J Pharm Pharmacol. 2004. PMID: 15099448

3

Novel iron-specific fluorescent probes.

Ma Y, Luo W, Camplo M, Liu Z, Hider RC. Ma Y, et al. Among authors: luo w. Bioorg Med Chem Lett. 2005 Jul 15;15(14):3450-2. doi: 10.1016/j.bmcl.2005.05.010. Bioorg Med Chem Lett. 2005. PMID: 15950474

4

Iron binding dendrimers: a novel approach for the treatment of haemochromatosis.

Zhou T, Neubert H, Liu DY, Liu ZD, Ma YM, Kong XL, Luo W, Mark S, Hider RC. Zhou T, et al. Among authors: luo w. J Med Chem. 2006 Jul 13;49(14):4171-82. doi: 10.1021/jm0600949. J Med Chem. 2006. PMID: 16821777

5

Discovery and evaluation of novel nitrodihydroimidazooxazoles as promising anti-tuberculosis agents.

Tao X, Gao C, Huang ZG, Luo W, Liu KL, Peng CT, Ding CZ, Li J, Chen SH, Yu LT. Tao X, et al. Among authors: luo w. Bioorg Med Chem Lett. 2019 Sep 1;29(17):2511-2515. doi: 10.1016/j.bmcl.2019.06.055. Epub 2019 Jun 28. Bioorg Med Chem Lett. 2019. PMID: 31353295

6

Synthesis and biological activities of dithiocarbamates containing 2(5H)-furanone-piperazine.

Wei MX, Zhang J, Ma FL, Li M, Yu JY, Luo W, Li XQ. Wei MX, et al. Among authors: luo w. Eur J Med Chem. 2018 Jul 15;155:165-170. doi: 10.1016/j.ejmech.2018.05.056. Epub 2018 Jun 4. Eur J Med Chem. 2018. PMID: 29886320

7

Synthesis and biological evaluation of immunosuppressive agent DZ2002 and its stereoisomers.

Zhang YM, Ding Y, Tang W, Luo W, Gu M, Lu W, Tang J, Zuo JP, Nan FJ. Zhang YM, et al. Among authors: luo w. Bioorg Med Chem. 2008 Oct 15;16(20):9212-6. doi: 10.1016/j.bmc.2008.09.017. Epub 2008 Sep 9. Bioorg Med Chem. 2008. PMID: 18815049

8

Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent.

Luo W, Huang Z, Xu D, Yang M, Zhu Y, Shen L, Chen S, Tao X, Bin W, Hu Y, Franzblau SG, Jiang N, Wei Y, Wei X, Ding CZ. Luo W, et al. Bioorg Med Chem Lett. 2022 Sep 15;72:128871. doi: 10.1016/j.bmcl.2022.128871. Epub 2022 Jun 28. Bioorg Med Chem Lett. 2022. PMID: 35777718

9

Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent.

Huang Z, Luo W, Xu D, Guo F, Yang M, Zhu Y, Shen L, Chen S, Tang D, Li L, Li Y, Wang B, Franzblau SG, Ding CZ. Huang Z, et al. Among authors: luo w. Bioorg Med Chem Lett. 2022 Sep 1;71:128824. doi: 10.1016/j.bmcl.2022.128824. Epub 2022 May 27. Bioorg Med Chem Lett. 2022. PMID: 35636648

10

Biallelic variants in SREBF2 cause autosomal recessive spastic paraplegia.

Wei Q, Fan W, Li HF, Wanga PS, Xu M, Dong HL, Yu H, Lyu J, Luo WJ, Chen DF, Ge W, Wu ZY. Wei Q, et al. Among authors: luo wj. J Genet Genomics. 2025 Jan 14:S1673-8527(25)00019-0. doi: 10.1016/j.jgg.2025.01.004. Online ahead of print. J Genet Genomics. 2025. PMID: 39814172

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,794 results

Search Page

Filters